Search This Blog

Tuesday, February 18, 2020

Passage Bio sets IPO terms

Gene therapy developer Passage Bio (PASG) has filed a prospectus for its IPO of 7.4M common shares at $16 – 18.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)